Narrow-Rim Functionalization of Calix[4]arene through Ugi-4CR Synthesis of a Series of Calix[4]arene

合集下载

曼氏无针乌贼肌肉cDNA文库的构建和表达序列标签分析

曼氏无针乌贼肌肉cDNA文库的构建和表达序列标签分析
DOI 1 . 9 9 J I S 1 0 — 1 0 2 . 3. 0 : 0 3 6 / . S N. 0 0 8 6 . 01 0 0 9 1
中 图 分 类 号 : 18 5 Q 7 .3
文献标识码 : A
文 章 编 号 :0 08 6 ( 0 )30 5 -6 10 —10 2 1 0 -37



Vo . 0. No 13 .3 Aug .,2 011
21 0 1年 8月
J OURNA O O EANOGR HY N AI AN T I L F C AP I T W S RA T
曼 氏无 针 乌贼 肌 肉 c N D A文 库 的 构 建 和 表 达 序 列 标 签 分 析
1 2 方 法 .
质资 源退 化 , 出现 个体 小 、 性早 熟 和 白化 卵 等问题 . 构建 S s 的分 析 , 其 功 能 进 行 推 ET ) 对
蒋霞敏 , 王 佳 , 良义 , 薛 曾建 刚
( 宁波大学生命科学与生物工 程学院 , 江 宁波 3 5 1 ) 浙 12 1
摘要: 以曼氏无针乌贼(eil m i r i肌 肉组织为研 究材料 , S ea an o ) p l d n 利用 Cot h cN
技术 的 发展 。 , 量人 工养 殖造 成 曼 氏无 针 乌贼 种 。 大
实验 乌贼 肌 肉组 织采 自浙江省 舟 山市六 横 海 区
野生 成 体 曼 氏无 针 乌 贼 (eil an rn) 提 取 Speam i oi. l d R A所用 Ti l 剂购 于上 海生 工生 物工 程有 限公 N ro 试 z 司. 建 c N 构 D A文 库 所 用 试 剂 盒 购 于 Co c leh公 司. t cN D A纯 化 柱 购 于 P am c hr ai 司. 肠 杆 菌 J 0 a公 大 M19 购 于 TK R a a a公 司. 他 常规试 剂 均为 国产 分析 纯 . 其

The Application of Functional Equivalence Theory i

The Application of Functional Equivalence Theory i

The Application of Functional Equivalence Theory into the Translation of Rhetorical Devices作者:Zhang Huahui Bo Ya-nan Yu Hongxia Cao Jianan来源:《读与写·教育教学版》2017年第12期Abstract:This paper analyzes how to adopt the Functional Equivalence Theory to figure out some effective translation strategies when dealing with rhetoric devices, including simile,metaphor and hyperbole. With the help of relevant theories and related examples, it analyses the use of literal translation, free translation, domestication and foreignization in the translation of rhetorical devices in the hope of helping students to gain practical translation strategies and to improve their translation skills regarding rhetorical devices and to apply what they have learnt into practice flexibly.Key words:Functional Equivalence Theory, Rhetorical Devices, translation strategies 中图分类号:H315.9 文献标识码:A 文章编号:1672-1578(2017)12-0001-021 IntroductionNida pointed that there are two equivalences. The first one is Formal Equivalence. It attaches great importance on the information delivered, in terms of both form and content. Another equivalence is dynamic equivalence, which is called the closest natural equivalence. [1]Nida held the view that translation was to use the naturalist way to reproduce the information of the original, firstly to reproduce the meaning, secondly style. But this theory still emphasizes what requires the reproduce is not the literal meaning and the word order of the original, but the idea and intention of the original. Therefore, the initial target of the translation is still the equivalence in contents, or the equivalence in meaning. Besides, the equivalence in style should be taken into the consideration:“Translation is composed of the tr anslated version with the closest equivalence of the original version,both of meanings and of styles.”[2]Functional Equivalence Theory does not refer to linguistic equivalence, but refers to the equivalence of linguistic function and psychological reaction of readers. Best translation means when the readers read the translation, it seems that they does not read translation but the original version. In order to make this happen, it is necessary to slip the leash that the linguistic structure of original exerts on translation.2 Major Translation TechniquesLiteral translation is the translation method that maintains both the original content and the original form. Literal translation can completely preserve the style and ethnic characteristics of the original. But literal translation must be readable, that is to say, the translation does not result in misunderstanding and does not violate the correct way of expression. Literal translation can also be applied to translate the sentences containing rhetorical devices.[3] To some extent, literal translation can not only preserve the characteristics of the original, but also enable the reader to gradually accept the literary style of the original. ”[4]Different from the literal translation, free translation or liberal translation refers to the translation of the original text, which does not translate word for word. We often apply liberal translation into the translation of sentences or larger groups of meaning, and free translation can be applied in the case of the cultural differences between the original version and the translated version. From the perspective of intercultural communication and the cultural system of the source language. Free translation can better reflect the language features of the nation.Domestication means the transformation of foreign culture, which is nationalization and localization. It takes the target culture as the ultimate goal. And it advocates that the translation should try to adapt to and take care of the target culture and the language translated to. It eliminates language and culture barriers for the readers and makes the translation smooth by narrowing the cultural differences as much as possible. [5]On the contrary, foreignization is to accept foreign culture or to become foreign. It is source culture oriented translation, which advocates that the translation should try to adapt to the culture of the source text and take care of the source language. Foreignization is to try to retain the linguistic and cultural features of the source language, in order to achieve the purpose of cultural exchange. Through foreignization, readers can understand the characteristics of the exotic culture.[6] For example:“Of all the gin joints in all the towns in the entire world,she walks out of mine.” The foreignization version would be:“这世上有那么多家旅馆,她终究还是走出了我的那一家。

Supramolecular host–guest polymeric materials

Supramolecular host–guest polymeric materials

Xian Jun Loh is currently a Research Scientist at the Institute of Materials Research and Engineering (IMRE) and an Assistant Professor at the National University of Singapore (NUS). He is also concurrently an adjunct scientist at the Singapore Eye Research Institute. He graduated with a PhD in 2009 from the National University of Singapore (NUS). He was awarded the National Science Talent Search Award in 1999, Agency for Science, Technology and Research (A*STAR) National Science Scholarship in 2002 (undergraduate studies) and A*STAR Graduate Scholarship in 2007 (postgraduate studies). He obtained a B.Appl.Sc. (1st Class Hons) in Applied Chemistry from NUS in 2006. Aer a one year attachment stint at IMRE, he continued his PhD studies in 2007. In 2011, he was elected into the Fellowship at Fitzwilliam College, Cambridge. He is the co-editor of an RSC-published book entitled “Polymeric and self-assembled hydrogels: from fundamental understanding to applications”. His main interests are in the design of supramolecular and stimuli-responsive polymers and hydrogels for biomedical applications. Currently, he is the author and co-author of 48 journal papers and 5 patents, publishing mainly in the area of biomaterials.

含杯芳烃聚合物的合成与应用

含杯芳烃聚合物的合成与应用
芳烃单元的有机硅树脂,并研究了其对过渡金属离
子和碱金属离子的吸附性能。Swager等[37,38]则在杯
[4]芳烃的下沿引入碘取代的并噻吩基团,通过偶联
反应制备了一系列杯[4]芳烃单元为“悬挂物”的聚
并噻吩、聚苯撑并噻吩等共轭高分子,发现其可以作
为Na+的选择性传感器。随后,他们又通过电化学
沿的一个酚羟基,再通过硼氢化反应将双键还原为
醇羟基,然后接入到单甲醚化PEG5000的链末端,
制备了聚合物负载的杯芳烃材料,其中杯芳烃空穴
能捕获NO+离子,可以作为NO2/N2O4的化学选择
性传感器。
2.2 共聚法
用共聚法实现杯芳烃单元作为侧基连接到聚合
物主链上,一般是通过在杯芳烃的上沿或者下沿引
酸化的杯[6]芳烃成功地作为侧基接枝到聚亚乙基
亚胺主链上,发现其能有效地选择性萃取UO22+。
Yilmaz小组[16—21]将带有不同取代基团的杯[4]
芳烃单元作为侧基连接到聚丙烯酰氯和聚氯甲基苯
乙烯的主链上,发现不同的取代基团分别对Na+、
Fe3+、Li+、Hg+、Cd2+以及重铬酸阴离子有较好的选
(图1c)[4]等。
杯芳烃本身具有多个紧密相连的羟基和一个π
体系洞穴,且上沿和下沿都易于选择性修饰,可以去
除或者引入适当的取代基,不仅可以固定所需要的
构象,还可以提高杯芳烃的溶解性,改善分子离子络
第20卷第5期
2008年5月
化 学 进 展
PROGRESS IN CHEMISTRY
Vol.20 No.5
calixarenes containing polymers is reviewed.

抗癌药英文课件

抗癌药英文课件

Interfere Transcription and Block RNA Synthesis
Bind with DNA to block RNA production.
doxorubicin
Influence the Structure and Function of DNA
Alkylating Agent: mechlorethamine, cyclophosphamide and thiotepa
抗癌药(Antineoplastic agents)
Overview
Introduction

Malignant disease accounts for a high proportion of deaths in industrialised countries.

The treatment of anticancer drug is to give palliation, induce remission and, if possible, cure.
The Basic Concept of Cell Generation Cycle
The cycle of cell replication includes: M(Mitosis)phase G1(Gap1, period before S)phase S(DNA synthesis)phase G2(Gap2,period after S)phase
The Classification of Anticancer Drugs

According to the cycle or phase specificity of the drug:
Cell cycle nonspecific agents (CCNSA) Cell cycle specific agents (CCSA)

Functional-Equivalence-Theory

Functional-Equivalence-Theory
2.The type of the audience:
Prospective audiences are different both in decoding ability and in potential interest.
第16页,共25页。
Three Basic Factors
3. The purpose of the author and of the translator: To give information on both form and content; to aim at full intelligibility of the reader so he/she may understand the full implications of the message; for imperative purposes that aim at not just understanding the translation but also at ensuring no misunderstanding of the translation.
1.The nature of the message: In some messages, the content should be of primary consideration, and in others the form must be given a higher priority.
Functional Equivalence is the core of his translation theory. According to Nida, translating consists in reproducing in the receptor language the closest natural equivalent of the source language message, first in terms of meaning and secondly in terms of style.

《磁共振成像》PPT课件

• Targeted contrast agents usually have higher relaxivities when interacting with the target due to the restriction of the rotational motion upon binding.
• The challenge is to prepare complexes that do not release the toxic metal ion in vivo and yet are efficient contrast agents.
2、Experimental Section
• The affinity of hydrophobic compounds with HSA is an ongoing topic in modern MRI research since both relaxivity and pharmacokinetics can be controlled by noncovalent binding of contrast agents to HSA.
• Aggregation
• Variable-temperature 17O NMR measurements
• Within the experimental error, the hyperfine coupling constant is identical to commonly observed values for oxygen atoms directly coordinated to Gd.
• We also performed NMRD measurements at 37℃ on a solution containing 4% HSA (0.6mm) and 1 (arameters are in the same range as those of the micellar aggregates and of the monomer.

分子生物学英文文献6

Chapter19Detection and Quantitative Analysis of Small RNAs by PCR Seungil Ro and Wei YanAbstractIncreasing lines of evidence indicate that small non-coding RNAs including miRNAs,piRNAs,rasiRNAs, 21U endo-siRNAs,and snoRNAs are involved in many critical biological processes.Functional studies of these small RNAs require a simple,sensitive,and reliable method for detecting and quantifying levels of small RNAs.Here,we describe such a method that has been widely used for the validation of cloned small RNAs and also for quantitative analyses of small RNAs in both tissues and cells.Key words:Small RNAs,miRNAs,piRNAs,expression,PCR.1.IntroductionThe past several years have witnessed the surprising discovery ofnumerous non-coding small RNAs species encoded by genomesof virtually all species(1–6),which include microRNAs(miR-NAs)(7–10),piwi-interacting RNAs(piRNAs)(11–14),repeat-associated siRNAs(rasiRNAs)(15–18),21U endo-siRNAs(19),and small nucleolar RNAs(snoRNAs)(20).These small RNAsare involved in all aspects of cellular functions through direct orindirect interactions with genomic DNAs,RNAs,and proteins.Functional studies on these small RNAs are just beginning,andsome preliminaryfindings have suggested that they are involvedin regulating genome stability,epigenetic marking,transcription,translation,and protein functions(5,21–23).An easy and sensi-tive method to detect and quantify levels of these small RNAs inorgans or cells during developmental courses,or under different M.Sioud(ed.),RNA Therapeutics,Methods in Molecular Biology629,DOI10.1007/978-1-60761-657-3_19,©Springer Science+Business Media,LLC2010295296Ro and Yanphysiological and pathophysiological conditions,is essential forfunctional studies.Quantitative analyses of small RNAs appear tobe challenging because of their small sizes[∼20nucleotides(nt)for miRNAs,∼30nt for piRNAs,and60–200nt for snoRNAs].Northern blot analysis has been the standard method for detec-tion and quantitative analyses of RNAs.But it requires a relativelylarge amount of starting material(10–20μg of total RNA or>5μg of small RNA fraction).It is also a labor-intensive pro-cedure involving the use of polyacrylamide gel electrophoresis,electrotransfer,radioisotope-labeled probes,and autoradiogra-phy.We have developed a simple and reliable PCR-based methodfor detection and quantification of all types of small non-codingRNAs.In this method,small RNA fractions are isolated and polyAtails are added to the3 ends by polyadenylation(Fig.19.1).Small RNA cDNAs(srcDNAs)are then generated by reverseFig.19.1.Overview of small RNA complementary DNA(srcDNA)library construction forPCR or qPCR analysis.Small RNAs are polyadenylated using a polyA polymerase.ThepolyA-tailed RNAs are reverse-transcribed using a primer miRTQ containing oligo dTsflanked by an adaptor sequence.RNAs are removed by RNase H from the srcDNA.ThesrcDNA is ready for PCR or qPCR to be carried out using a small RNA-specific primer(srSP)and a universal reverse primer,RTQ-UNIr.Quantitative Analysis of Small RNAs297transcription using a primer consisting of adaptor sequences atthe5 end and polyT at the3 end(miRTQ).Using the srcD-NAs,non-quantitative or quantitative PCR can then be per-formed using a small RNA-specific primer and the RTQ-UNIrprimer.This method has been utilized by investigators in numer-ous studies(18,24–38).Two recent technologies,454sequenc-ing and microarray(39,40)for high-throughput analyses of miR-NAs and other small RNAs,also need an independent method forvalidation.454sequencing,the next-generation sequencing tech-nology,allows virtually exhaustive sequencing of all small RNAspecies within a small RNA library.However,each of the clonednovel small RNAs needs to be validated by examining its expres-sion in organs or in cells.Microarray assays of miRNAs have beenavailable but only known or bioinformatically predicted miR-NAs are covered.Similar to mRNA microarray analyses,the up-or down-regulation of miRNA levels under different conditionsneeds to be further validated using conventional Northern blotanalyses or PCR-based methods like the one that we are describ-ing here.2.Materials2.1.Isolation of Small RNAs, Polyadenylation,and Purification 1.mirVana miRNA Isolation Kit(Ambion).2.Phosphate-buffered saline(PBS)buffer.3.Poly(A)polymerase.4.mirVana Probe and Marker Kit(Ambion).2.2.Reverse Transcription,PCR, and Quantitative PCR 1.Superscript III First-Strand Synthesis System for RT-PCR(Invitrogen).2.miRTQ primers(Table19.1).3.AmpliTaq Gold PCR Master Mix for PCR.4.SYBR Green PCR Master Mix for qPCR.5.A miRNA-specific primer(e.g.,let-7a)and RTQ-UNIr(Table19.1).6.Agarose and100bp DNA ladder.3.Methods3.1.Isolation of Small RNAs 1.Harvest tissue(≤250mg)or cells in a1.7-mL tube with500μL of cold PBS.T a b l e 19.1O l i g o n u c l e o t i d e s u s e dN a m eS e q u e n c e (5 –3 )N o t eU s a g em i R T QC G A A T T C T A G A G C T C G A G G C A G G C G A C A T G G C T G G C T A G T T A A G C T T G G T A C C G A G C T A G T C C T T T T T T T T T T T T T T T T T T T T T T T T T V N ∗R N a s e f r e e ,H P L CR e v e r s e t r a n s c r i p t i o nR T Q -U N I r C G A A T T C T A G A G C T C G A G G C A G GR e g u l a r d e s a l t i n gP C R /q P C Rl e t -7a T G A G G T A G T A G G T T G T A T A G R e g u l a r d e s a l t i n gP C R /q P C R∗V =A ,C ,o r G ;N =A ,C ,G ,o r TQuantitative Analysis of Small RNAs299 2.Centrifuge at∼5,000rpm for2min at room temperature(RT).3.Remove PBS as much as possible.For cells,remove PBScarefully without breaking the pellet,leave∼100μL of PBS,and resuspend cells by tapping gently.4.Add300–600μL of lysis/binding buffer(10volumes pertissue mass)on ice.When you start with frozen tissue or cells,immediately add lysis/binding buffer(10volumes per tissue mass)on ice.5.Cut tissue into small pieces using scissors and grind it usinga homogenizer.For cells,skip this step.6.Vortex for40s to mix.7.Add one-tenth volume of miRNA homogenate additive onice and mix well by vortexing.8.Leave the mixture on ice for10min.For tissue,mix it every2min.9.Add an equal volume(330–660μL)of acid-phenol:chloroform.Be sure to withdraw from the bottom phase(the upper phase is an aqueous buffer).10.Mix thoroughly by inverting the tubes several times.11.Centrifuge at10,000rpm for5min at RT.12.Recover the aqueous phase carefully without disrupting thelower phase and transfer it to a fresh tube.13.Measure the volume using a scale(1g=∼1mL)andnote it.14.Add one-third volume of100%ethanol at RT to the recov-ered aqueous phase.15.Mix thoroughly by inverting the tubes several times.16.Transfer up to700μL of the mixture into afilter cartridgewithin a collection bel thefilter as total RNA.When you have>700μL of the mixture,apply it in suc-cessive application to the samefilter.17.Centrifuge at10,000rpm for15s at RT.18.Collect thefiltrate(theflow-through).Save the cartridgefor total RNA isolation(go to Step24).19.Add two-third volume of100%ethanol at RT to theflow-through.20.Mix thoroughly by inverting the tubes several times.21.Transfer up to700μL of the mixture into a newfilterbel thefilter as small RNA.When you have >700μL of thefiltrate mixture,apply it in successive appli-cation to the samefilter.300Ro and Yan22.Centrifuge at10,000rpm for15s at RT.23.Discard theflow-through and repeat until all of thefiltratemixture is passed through thefilter.Reuse the collectiontube for the following washing steps.24.Apply700μL of miRNA wash solution1(working solu-tion mixed with ethanol)to thefilter.25.Centrifuge at10,000rpm for15s at RT.26.Discard theflow-through.27.Apply500μL of miRNA wash solution2/3(working solu-tion mixed with ethanol)to thefilter.28.Centrifuge at10,000rpm for15s at RT.29.Discard theflow-through and repeat Step27.30.Centrifuge at12,000rpm for1min at RT.31.Transfer thefilter cartridge to a new collection tube.32.Apply100μL of pre-heated(95◦C)elution solution orRNase-free water to the center of thefilter and close thecap.Aliquot a desired amount of elution solution intoa1.7-mL tube and heat it on a heat block at95◦C for∼15min.Open the cap carefully because it might splashdue to pressure buildup.33.Leave thefilter tube alone for1min at RT.34.Centrifuge at12,000rpm for1min at RT.35.Measure total RNA and small RNA concentrations usingNanoDrop or another spectrophotometer.36.Store it at–80◦C until used.3.2.Polyadenylation1.Set up a reaction mixture with a total volume of50μL in a0.5-mL tube containing0.1–2μg of small RNAs,10μL of5×E-PAP buffer,5μL of25mM MnCl2,5μL of10mMATP,1μL(2U)of Escherichia coli poly(A)polymerase I,and RNase-free water(up to50μL).When you have a lowconcentration of small RNAs,increase the total volume;5×E-PAP buffer,25mM MnCl2,and10mM ATP should beincreased accordingly.2.Mix well and spin the tube briefly.3.Incubate for1h at37◦C.3.3.Purification 1.Add an equal volume(50μL)of acid-phenol:chloroformto the polyadenylation reaction mixture.When you have>50μL of the mixture,increase acid-phenol:chloroformaccordingly.2.Mix thoroughly by tapping the tube.Quantitative Analysis of Small RNAs3013.Centrifuge at10,000rpm for5min at RT.4.Recover the aqueous phase carefully without disrupting thelower phase and transfer it to a fresh tube.5.Add12volumes(600μL)of binding/washing buffer tothe aqueous phase.When you have>50μL of the aqueous phase,increase binding/washing buffer accordingly.6.Transfer up to460μL of the mixture into a purificationcartridge within a collection tube.7.Centrifuge at10,000rpm for15s at RT.8.Discard thefiltrate(theflow-through)and repeat until allof the mixture is passed through the cartridge.Reuse the collection tube.9.Apply300μL of binding/washing buffer to the cartridge.10.Centrifuge at12,000rpm for1min at RT.11.Transfer the cartridge to a new collection tube.12.Apply25μL of pre-heated(95◦C)elution solution to thecenter of thefilter and close the cap.Aliquot a desired amount of elution solution into a1.7-mL tube and heat it on a heat block at95◦C for∼15min.Open the cap care-fully because it might be splash due to pressure buildup.13.Let thefilter tube stand for1min at RT.14.Centrifuge at12,000rpm for1min at RT.15.Repeat Steps12–14with a second aliquot of25μL ofpre-heated(95◦C)elution solution.16.Measure polyadenylated(tailed)RNA concentration usingNanoDrop or another spectrophotometer.17.Store it at–80◦C until used.After polyadenylation,RNAconcentration should increase up to5–10times of the start-ing concentration.3.4.Reverse Transcription 1.Mix2μg of tailed RNAs,1μL(1μg)of miRTQ,andRNase-free water(up to21μL)in a PCR tube.2.Incubate for10min at65◦C and for5min at4◦C.3.Add1μL of10mM dNTP mix,1μL of RNaseOUT,4μLof10×RT buffer,4μL of0.1M DTT,8μL of25mM MgCl2,and1μL of SuperScript III reverse transcriptase to the mixture.When you have a low concentration of lig-ated RNAs,increase the total volume;10×RT buffer,0.1M DTT,and25mM MgCl2should be increased accordingly.4.Mix well and spin the tube briefly.5.Incubate for60min at50◦C and for5min at85◦C toinactivate the reaction.302Ro and Yan6.Add1μL of RNase H to the mixture.7.Incubate for20min at37◦C.8.Add60μL of nuclease-free water.3.5.PCR and qPCR 1.Set up a reaction mixture with a total volume of25μL ina PCR tube containing1μL of small RNA cDNAs(srcD-NAs),1μL(5pmol of a miRNA-specific primer(srSP),1μL(5pmol)of RTQ-UNIr,12.5μL of AmpliTaq GoldPCR Master Mix,and9.5μL of nuclease-free water.ForqPCR,use SYBR Green PCR Master Mix instead of Ampli-Taq Gold PCR Master Mix.2.Mix well and spin the tube briefly.3.Start PCR or qPCR with the conditions:95◦C for10minand then40cycles at95◦C for15s,at48◦C for30s and at60◦C for1min.4.Adjust annealing Tm according to the Tm of your primer5.Run2μL of the PCR or qPCR products along with a100bpDNA ladder on a2%agarose gel.∼PCR products should be∼120–200bp depending on the small RNA species(e.g.,∼120–130bp for miRNAs and piRNAs).4.Notes1.This PCR method can be used for quantitative PCR(qPCR)or semi-quantitative PCR(semi-qPCR)on small RNAs suchas miRNAs,piRNAs,snoRNAs,small interfering RNAs(siRNAs),transfer RNAs(tRNAs),and ribosomal RNAs(rRNAs)(18,24–38).2.Design miRNA-specific primers to contain only the“coresequence”since our cloning method uses two degeneratenucleotides(VN)at the3 end to make small RNA cDNAs(srcDNAs)(see let-7a,Table19.1).3.For qPCR analysis,two miRNAs and a piRNA were quan-titated using the SYBR Green PCR Master Mix(41).Cyclethreshold(Ct)is the cycle number at which thefluorescencesignal reaches the threshold level above the background.ACt value for each miRNA tested was automatically calculatedby setting the threshold level to be0.1–0.3with auto base-line.All Ct values depend on the abundance of target miR-NAs.For example,average Ct values for let-7isoforms rangefrom17to20when25ng of each srcDNA sample from themultiple tissues was used(see(41).Quantitative Analysis of Small RNAs3034.This method amplifies over a broad dynamic range up to10orders of magnitude and has excellent sensitivity capable ofdetecting as little as0.001ng of the srcDNA in qPCR assays.5.For qPCR,each small RNA-specific primer should be testedalong with a known control primer(e.g.,let-7a)for PCRefficiency.Good efficiencies range from90%to110%calcu-lated from slopes between–3.1and–3.6.6.On an agarose gel,mature miRNAs and precursor miRNAs(pre-miRNAs)can be differentiated by their size.PCR prod-ucts containing miRNAs will be∼120bp long in size whileproducts containing pre-miRNAs will be∼170bp long.However,our PCR method preferentially amplifies maturemiRNAs(see Results and Discussion in(41)).We testedour PCR method to quantify over100miRNAs,but neverdetected pre-miRNAs(18,29–31,38). AcknowledgmentsThe authors would like to thank Jonathan Cho for reading andediting the text.This work was supported by grants from theNational Institute of Health(HD048855and HD050281)toW.Y.References1.Ambros,V.(2004)The functions of animalmicroRNAs.Nature,431,350–355.2.Bartel,D.P.(2004)MicroRNAs:genomics,biogenesis,mechanism,and function.Cell, 116,281–297.3.Chang,T.C.and Mendell,J.T.(2007)Theroles of microRNAs in vertebrate physiol-ogy and human disease.Annu Rev Genomics Hum Genet.4.Kim,V.N.(2005)MicroRNA biogenesis:coordinated cropping and dicing.Nat Rev Mol Cell Biol,6,376–385.5.Kim,V.N.(2006)Small RNAs just gotbigger:Piwi-interacting RNAs(piRNAs) in mammalian testes.Genes Dev,20, 1993–1997.6.Kotaja,N.,Bhattacharyya,S.N.,Jaskiewicz,L.,Kimmins,S.,Parvinen,M.,Filipowicz, W.,and Sassone-Corsi,P.(2006)The chro-matoid body of male germ cells:similarity with processing bodies and presence of Dicer and microRNA pathway components.Proc Natl Acad Sci U S A,103,2647–2652.7.Aravin,A.A.,Lagos-Quintana,M.,Yalcin,A.,Zavolan,M.,Marks,D.,Snyder,B.,Gaaster-land,T.,Meyer,J.,and Tuschl,T.(2003) The small RNA profile during Drosophilamelanogaster development.Dev Cell,5, 337–350.8.Lee,R.C.and Ambros,V.(2001)An exten-sive class of small RNAs in Caenorhabditis ele-gans.Science,294,862–864.u,N.C.,Lim,L.P.,Weinstein, E.G.,and Bartel,D.P.(2001)An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans.Science,294, 858–862.gos-Quintana,M.,Rauhut,R.,Lendeckel,W.,and Tuschl,T.(2001)Identification of novel genes coding for small expressed RNAs.Science,294,853–858.u,N.C.,Seto,A.G.,Kim,J.,Kuramochi-Miyagawa,S.,Nakano,T.,Bartel,D.P.,and Kingston,R.E.(2006)Characterization of the piRNA complex from rat testes.Science, 313,363–367.12.Grivna,S.T.,Beyret,E.,Wang,Z.,and Lin,H.(2006)A novel class of small RNAs inmouse spermatogenic cells.Genes Dev,20, 1709–1714.13.Girard, A.,Sachidanandam,R.,Hannon,G.J.,and Carmell,M.A.(2006)A germline-specific class of small RNAs binds mammalian Piwi proteins.Nature,442,199–202.304Ro and Yan14.Aravin,A.,Gaidatzis,D.,Pfeffer,S.,Lagos-Quintana,M.,Landgraf,P.,Iovino,N., Morris,P.,Brownstein,M.J.,Kuramochi-Miyagawa,S.,Nakano,T.,Chien,M.,Russo, J.J.,Ju,J.,Sheridan,R.,Sander,C.,Zavolan, M.,and Tuschl,T.(2006)A novel class of small RNAs bind to MILI protein in mouse testes.Nature,442,203–207.15.Watanabe,T.,Takeda, A.,Tsukiyama,T.,Mise,K.,Okuno,T.,Sasaki,H.,Minami, N.,and Imai,H.(2006)Identification and characterization of two novel classes of small RNAs in the mouse germline: retrotransposon-derived siRNAs in oocytes and germline small RNAs in testes.Genes Dev,20,1732–1743.16.Vagin,V.V.,Sigova,A.,Li,C.,Seitz,H.,Gvozdev,V.,and Zamore,P.D.(2006)A distinct small RNA pathway silences selfish genetic elements in the germline.Science, 313,320–324.17.Saito,K.,Nishida,K.M.,Mori,T.,Kawa-mura,Y.,Miyoshi,K.,Nagami,T.,Siomi,H.,and Siomi,M.C.(2006)Specific asso-ciation of Piwi with rasiRNAs derived from retrotransposon and heterochromatic regions in the Drosophila genome.Genes Dev,20, 2214–2222.18.Ro,S.,Song,R.,Park, C.,Zheng,H.,Sanders,K.M.,and Yan,W.(2007)Cloning and expression profiling of small RNAs expressed in the mouse ovary.RNA,13, 2366–2380.19.Ruby,J.G.,Jan,C.,Player,C.,Axtell,M.J.,Lee,W.,Nusbaum,C.,Ge,H.,and Bartel,D.P.(2006)Large-scale sequencing reveals21U-RNAs and additional microRNAs and endogenous siRNAs in C.elegans.Cell,127, 1193–1207.20.Terns,M.P.and Terns,R.M.(2002)Small nucleolar RNAs:versatile trans-acting molecules of ancient evolutionary origin.Gene Expr,10,17–39.21.Ouellet,D.L.,Perron,M.P.,Gobeil,L.A.,Plante,P.,and Provost,P.(2006)MicroR-NAs in gene regulation:when the smallest governs it all.J Biomed Biotechnol,2006, 69616.22.Maatouk,D.and Harfe,B.(2006)MicroR-NAs in development.ScientificWorldJournal, 6,1828–1840.23.Kim,V.N.and Nam,J.W.(2006)Genomics of microRNA.Trends Genet,22, 165–173.24.Bohnsack,M.T.,Kos,M.,and Tollervey,D.(2008)Quantitative analysis of snoRNAassociation with pre-ribosomes and release of snR30by Rok1helicase.EMBO Rep,9, 1230–1236.25.Hertel,J.,de Jong, D.,Marz,M.,Rose,D.,Tafer,H.,Tanzer, A.,Schierwater,B.,and Stadler,P.F.(2009)Non-codingRNA annotation of the genome of Tri-choplax adhaerens.Nucleic Acids Res,37, 1602–1615.26.Kim,M.,Patel,B.,Schroeder,K.E.,Raza,A.,and Dejong,J.(2008)Organization andtranscriptional output of a novel mRNA-like piRNA gene(mpiR)located on mouse chro-mosome10.RNA,14,1005–1011.27.Mishima,T.,Takizawa,T.,Luo,S.S.,Ishibashi,O.,Kawahigashi,Y.,Mizuguchi, Y.,Ishikawa,T.,Mori,M.,Kanda,T., and Goto,T.(2008)MicroRNA(miRNA) cloning analysis reveals sex differences in miRNA expression profiles between adult mouse testis and ovary.Reproduction,136, 811–822.28.Papaioannou,M.D.,Pitetti,J.L.,Ro,S.,Park, C.,Aubry, F.,Schaad,O.,Vejnar,C.E.,Kuhne, F.,Descombes,P.,Zdob-nov, E.M.,McManus,M.T.,Guillou, F., Harfe,B.D.,Yan,W.,Jegou,B.,and Nef, S.(2009)Sertoli cell Dicer is essential for spermatogenesis in mice.Dev Biol,326, 250–259.29.Ro,S.,Park,C.,Sanders,K.M.,McCarrey,J.R.,and Yan,W.(2007)Cloning and expres-sion profiling of testis-expressed microRNAs.Dev Biol,311,592–602.30.Ro,S.,Park,C.,Song,R.,Nguyen,D.,Jin,J.,Sanders,K.M.,McCarrey,J.R.,and Yan, W.(2007)Cloning and expression profiling of testis-expressed piRNA-like RNAs.RNA, 13,1693–1702.31.Ro,S.,Park,C.,Young,D.,Sanders,K.M.,and Yan,W.(2007)Tissue-dependent paired expression of miRNAs.Nucleic Acids Res, 35,5944–5953.32.Siebolts,U.,Varnholt,H.,Drebber,U.,Dienes,H.P.,Wickenhauser,C.,and Oden-thal,M.(2009)Tissues from routine pathol-ogy archives are suitable for microRNA anal-yses by quantitative PCR.J Clin Pathol,62, 84–88.33.Smits,G.,Mungall,A.J.,Griffiths-Jones,S.,Smith,P.,Beury,D.,Matthews,L.,Rogers, J.,Pask, A.J.,Shaw,G.,VandeBerg,J.L., McCarrey,J.R.,Renfree,M.B.,Reik,W.,and Dunham,I.(2008)Conservation of the H19 noncoding RNA and H19-IGF2imprint-ing mechanism in therians.Nat Genet,40, 971–976.34.Song,R.,Ro,S.,Michaels,J.D.,Park,C.,McCarrey,J.R.,and Yan,W.(2009)Many X-linked microRNAs escape meiotic sex chromosome inactivation.Nat Genet,41, 488–493.Quantitative Analysis of Small RNAs30535.Wang,W.X.,Wilfred,B.R.,Baldwin,D.A.,Isett,R.B.,Ren,N.,Stromberg, A.,and Nelson,P.T.(2008)Focus on RNA iso-lation:obtaining RNA for microRNA (miRNA)expression profiling analyses of neural tissue.Biochim Biophys Acta,1779, 749–757.36.Wu,F.,Zikusoka,M.,Trindade,A.,Das-sopoulos,T.,Harris,M.L.,Bayless,T.M., Brant,S.R.,Chakravarti,S.,and Kwon, J.H.(2008)MicroRNAs are differen-tially expressed in ulcerative colitis and alter expression of macrophage inflam-matory peptide-2alpha.Gastroenterology, 135(1624–1635),e24.37.Wu,H.,Neilson,J.R.,Kumar,P.,Manocha,M.,Shankar,P.,Sharp,P.A.,and Manjunath, N.(2007)miRNA profiling of naive,effec-tor and memory CD8T cells.PLoS ONE,2, e1020.38.Yan,W.,Morozumi,K.,Zhang,J.,Ro,S.,Park, C.,and Yanagimachi,R.(2008) Birth of mice after intracytoplasmic injec-tion of single purified sperm nuclei and detection of messenger RNAs and microR-NAs in the sperm nuclei.Biol Reprod,78, 896–902.39.Guryev,V.and Cuppen,E.(2009)Next-generation sequencing approaches in genetic rodent model systems to study func-tional effects of human genetic variation.FEBS Lett.40.Li,W.and Ruan,K.(2009)MicroRNAdetection by microarray.Anal Bioanal Chem.41.Ro,S.,Park,C.,Jin,JL.,Sanders,KM.,andYan,W.(2006)A PCR-based method for detection and quantification of small RNAs.Biochem and Biophys Res Commun,351, 756–763.。

参考文献标准格式(国家标准)

一、参考文献的类型>>详细国家标准参考文献(即引文出处)的类型以单字母方式标识,具体如下:M——专著C——论文集N——报纸文章J——期刊文章D——学位论文R——报告对于不属于上述的文献类型,采用字母“Z”标识。

对于英文参考文献,还应注意以下两点:①作者姓名采用“姓在前名在后”原则,具体格式是:姓,名字的首字母. 如:Malcolm Richard Cowley 应为:Cowley, M.R.,如果有两位作者,第一位作者方式不变,&之后第二位作者名字的首字母放在前面,姓放在后面,如:Frank Norris 与Irving Gordon应为:Norris,F. & I.Gordon.;②书名、报刊名使用斜体字,如:Mastering English Literature,English Weekly。

二、参考文献的格式及举例1.期刊类【格式】[序号]作者.篇名[J].刊名,出版年份,卷号(期号):起止页码.【举例】[1] 王海粟.浅议会计信息披露模式[J].财政研究,2004,21(1):56-58.[2] 夏鲁惠.高等学校毕业论文教学情况调研报告[J].高等理科教育,2004(1):46-52.[3] Heider, E.R.& D.C.Oliver. The structure of color space in naming and memory of two languages [J]. Foreign Language Teaching and Research, 1999, (3): 62 – 67.2.图书类【格式】[序号]作者.书名[M].出版地:出版社,出版年份:起止页码.【举例】[4] 葛家澍,林志军.现代西方财务会计理论[M].厦门:厦门大学出版社,2001:42.[5] Gill, R. Mastering English Literature [M]. London: Macmillan, 1985: 42-45.3.报纸类【格式】[序号]作者.篇名[N].报纸名,出版日期(版次).【举例】[6] 李大伦.经济全球化的重要性[N]. 光明日报,1998-12-27(3).[7] French, W. Between Silences: A V oice from China[N]. Atlantic Weekly, 1987-8-15(33).4.论文集【格式】[序号]作者.篇名[C].出版地:出版者,出版年份:起始页码.【举例】[8] 伍蠡甫.西方文论选[C]. 上海:上海译文出版社,1979:12-17.[9] Spivak,G. “Can the Subaltern Speak?”[A]. In C.Nelson & L. Grossberg(eds.). Victory in Limbo: Imigism [C]. Urbana: University of Illinois Press, 1988, pp.271-313.[10] Almarza, G.G. Student foreign language teacher’s knowledge growth [A]. In D.Freeman and J.C.Richards (eds.). Teacher Learning in Language Teaching [C]. New York: Cambridge University Press. 1996. pp.50-78.5.学位论文【格式】[序号]作者.篇名[D].出版地:保存者,出版年份:起始页码.【举例】[11] 张筑生.微分半动力系统的不变集[D].北京:北京大学数学系数学研究所, 1983:1-7. 6.研究报告【格式】[序号]作者.篇名[R].出版地:出版者,出版年份:起始页码.【举例】[12] 冯西桥.核反应堆压力管道与压力容器的LBB分析[R].北京:清华大学核能技术设计研究院, 1997:9-10.7.条例【格式】[序号]颁布单位.条例名称.发布日期【举例】[15] 中华人民共和国科学技术委员会.科学技术期刊管理办法[Z].1991—06—058.译著【格式】[序号]原著作者. 书名[M].译者,译.出版地:出版社,出版年份:起止页码.。

非希氏内科学词缀

CT Scan1.radio-ray 放射,辐射radiation 辐射radiologist 放射线研究者2.ren(o)- kidney 肾renal 肾脏的renogram肾探测图3.abdomino- the belly 腹abdominal腹部的4.tom(o) a cutting 切割tomography断层摄影术5.acu- 针,尖锐acute 急性的,尖声的6.appendic(o)- 附件(尤指阑尾)appendicitis 阑尾炎X-Ray1. ion- 离子ion ize ['aɪənaɪz] 离子化vt. 电离;使离子化ion osphere[aɪ'ɒnəsfɪə] [地物] 电离层2. nucleo- 核nucleo n ['nʊklɪɑn] [高能] 核子nucleo nic[,nju:kli'ɔnik] 核的;核子的3.cosmo-宇宙宇宙的cosm ic ['kɒzmɪk] 宇宙的4. electro-电,电子的electro[ɪ'lektrəʊ] 电镀物品vt. 电镀electro nic [ɪlek'trɒnɪk; el-] 电子的5. gene- [dʒi:n] 基因gene tic a[dʒɪ'netɪk] 遗传的;基因的;起源的6. epidemio- 流行epidemio logist[,ɛpɪ,dimɪ'ɑlədʒɪst] 流行病学家epidemio logical['ɛpɪ,dimɪr'lɑdʒɪkl] 流行病学的Cancer Patients Challenge the Patenting of a Gene 1.cyst(o)- 囊,囊肿;膀胱cyst ic ['sistik] 【解剖学】胆囊的;膀胱的cyst itis [sis'taitis] n.【病理学】膀胱炎cystoid ['sistɔid] 似囊肿的;胞囊状的2. fibro- fiber 纤维fibrocystic [,faibrə'sistik] 【解剖学】纤维囊性的fibro sis [fai'brəusis] 【病理学】纤维变性,纤维化fibro ma [fai'brəumə] 【病理学】纤维瘤3. mast(o)- 乳房,乳突mast itiis[mæs'tatis]【病理学】乳腺炎,乳房炎mas toid ['mæstɔid] 【解剖学】乳突,乳突骨mast ic ['mæstɪk] 乳香4. –ectomy 切除术Append ectomy [,æpen'dektəmi] [外科] 阑尾切除术cyst ectomy [sis'tektəmi]胆囊切除术;膀胱切除术mast ectomy [mæ'stektəmi]乳房切除术5. mon(o)-单一,部分;(化学)一价mono drama ['mɔnəu,drɑ:mə] n.独脚戏;单人剧mono gamy [mɔ'nɔɡəmi; mə-] 一夫一妻制,单配偶mono cracy [mɔ'nɔkrəsi] 独裁政治6. hem(o)- blood 血hem al [‘hi:məl] 血管的,血液的hem atin ['hemətin] 血色素hem atology [,hemə'tɔlədʒi] 血液学7. chromo- 色chromo gen['krəumədʒən] 色原,色原体chromo some ['krəuməsəum] 【遗传学】染色体chromo sphere ['krəumə,sfiə] 【天文学】(太阳的)色球(层)HIV testing1.-let 小plate let [‘pleitlit] 血小板crate rlet [‘kreitəlit]小火山口;小坑洞armlet ['ɑ:mlit] 小海湾,小河湾2. retro- 向后,后面retro grade [‘retrəuɡreid] 倒退;退步retro spect ['retrəuspekt] 回忆,回顾;追溯retro rocket ['retrəu,rɔkit] 反向火箭3.ante- 在…前面;在…之前ante room 前厅;接待室ante natal [,ænti'neitəl] 出生前的,产前的ante date 比实际提前的日期4. hepat(o)-liver 肝hepat ic [hi‘pætik] 肝的,肝状的hepat itis [,hepə‘taitis] 肝炎hepat oma [,hepə'təumə] 肝癌,肝细胞瘤5. nat- 生,出生nat al [‘neitəl] 出生的;分娩的nat ality [nei'tæləti] 出生率;生产率Introduction to Physiology1. ana- 1. 向上,2.向后ana batic [,ænə‘bætɪk] 上升的ana bolism [ə‘næbəulizəm] 合成代谢ana plasia [,ænə'pleisiə] 【病理学】(细胞)退行发育2. cata- 向下,下,在下cata comb ['kætəkəum] 地下墓穴,陵寝cata dromous [kə'tædrəməs] (某些淡水鱼)下海产卵的,下海繁殖的cata bolism [kə'tæbəlizəm]分解代谢3. epi- 在…上面;在…外面epi condyle [,epi'kɔndail] 【解剖学】上髁epi blast [‘epiblæst]外胚层;外胚叶epi cardium [,epi'kɑ:diəm]【解剖学】心外膜,心脏包层4. gluc- 甜的,含糖的glucose [‘ɡlu:kəus]葡萄糖gluc agon ['ɡlu:kəɡɔn] 【生物化学】胰高血糖素gluc oside ['ɡlu:kəusaid] 葡萄糖苷5. gon-性的;再生的gon ophore ['ɡɔnəufɔ:]副生殖器(例如输卵管、子宫、输精管、精囊等)gon opore 【动物学】生殖孔6. extra- 在…之外,超出:extra cellular [,ekstrə‘seljulə] 细胞外的extra cranial [,ekstrə‘kreiniəl] 颅外的extra code ['ekstrə,kəud] 附加码;附加程序7. homeo- 象;相似:homeo pathy [,həumi'ɔpəθi] 同种疗法;顺势疗法homeo stasis[,həumiəu'steisis][生理] 体内平衡8. –ose糖fruct ose [‘frʌktəus] 【化学】果糖;左旋糖gluc ose['ɡlu:kəus] 葡萄糖9. –stasis稳定状态;抑制,停止homeo stasis[,həumiəu'steisis] [生理] 体内平衡bacterio stasis [bæk'tiəriə'steisis] 【微生物学】抑菌作用10. loco- 从一处至另一处loco motion ['ləukə'məuʃən] 运动;移动loco motor [,ləukə'məutə]运动的;移动的11. nitro-氮nitro gen [‘naitrədʒən] 【化学】氮nitro us ['naitrəs]氮的;含氮的12. osmo- 鼻,渗透,嗅觉osm atic [ɔz'mætik; ɔs-] 嗅觉的;具有嗅觉的osmo sis [ɔz'məusis] 渗透(作用)osmo meter [ɔz'mɔmitə] 【化学】渗压计13. broncho- 支气管;小支气管的bronch us ['brɔŋkəs] 支气管broncho scope ['brɔŋkəskəup] 【医学】支气管镜14. musculo- [医]肌muscul ar ['mʌskjulə] 肌肉的;【解剖学】肌的muscul in 肌蛋白15. somato-躯体,体细胞somato logy [,səumə'tɔlədʒi] 人类躯体学;人体学somato plasm ['səumətəplæzəm] 体细胞16. lympho-淋巴系统;淋巴lympho cyte ['limfəusait] 【解剖学】淋巴细胞;lympho id ['limfɔid]淋巴的;淋巴样的17.ox-氧ox ygen ['ɔksidʒən] 氧;氧气ox idant ['ɔksidənt] 氧化剂dio xi de [dai'ɔksaid] 二氧化物18. dys- 不正常的dys plasia [dis'pleiziə] 发育不良;发育异常dys function [dis'fʌŋkʃən] 【医学】(器官)功能紊乱,机能不良(或失调),机能障碍Babiesscler(o)- 硬化;巩膜sclero sis [sklɪə'rəʊsɪs; sklə-] [sklə'rosɪs]n. [病理] 硬化,[医] 硬化症;细胞壁硬化enter(o)- 肠entero logy n. [内科] 肠病学;胃肠病学gastro enter ologyn 肠胃病学ultra- 过度,超,限外ultra clean 特净的,超洁的bacteri(o)- 细菌bacteri um (pl. bacteria) 细菌colo- 结肠colo n 结肠。

  1. 1、下载文档前请自行甄别文档内容的完整性,平台不提供额外的编辑、内容补充、找答案等附加服务。
  2. 2、"仅部分预览"的文档,不可在线预览部分如存在完整性等问题,可反馈申请退款(可完整预览的文档不适用该条件!)。
  3. 3、如文档侵犯您的权益,请联系客服反馈,我们会尽快为您处理(人工客服工作时间:9:00-18:30)。

INTRODUCTION Calixarenes, which are probably the most readily available synthetic molecular baskets, enjoy a considerable reputation for being applied in diverse areas.1 The incredible development of calix[4]arenes as molecular receptors is related to the many possible structural and functional modifications of their core molecular architecture,2 which constitutes a hollow cavity flanked by a hydrophobic upper rim and a hydrophilic lower rim. The introduction of suitable donor groups at the lower rim and upper rim of calixarenes produces powerful and selective ionophores, particularly for spherical metal ions. Among the various calix[4]arene derivatives, those adorned with multivalent groups such as peptides or peptide-like motifs are attractive in host−guest chemistry, since they provide a variety of functional groupshydrophobic, polar, and charged groupsthat can interact with other molecules through hydrogen-bonding, electrostatic, and van der Waals interactions. In addition, amino acid units introduce chirality and afford the potential for stereoselective recognition.3,4 The most widely investigated peptidocalixarenes are those bearing amino acids at the lower rim,5 particularly due to their ability to bind small molecules and metals. The synthesis of such calixarenes involves selective protection of the lower rim followed by multiple steps using established techniques for the formation of peptide bonds. Among narrow-rim functionalizations of calix[4]arenes, 1,3-disubstitution at the lower rim has become more attractive due to the presence of two phenolic OH groups (which provide extra coordination sites) and its ability to maintain a cone

Chemical Sciences and Technology Division and ‡Academy of Scientific and Innovative Research (AcSIR), National Institute for Interdisciplinary Science and Technology (NIIST)-CSIR, Trivandrum 695019, India
© 2014 American Chemical Society

conformation by retaining two hydrogen bonds at the lower rim. A number of 1,3-diconjugates of calix[4]arene are known in the literature for their ion and molecular recognition.6 As part of our general interest in calixarene chemistry, we have been involved in working out the potential for functionalizing calix[4]arene with multivalent groups using a multicomponent strategy. We have successfully demonstrated the synthetic utility of the multicomponent methodology toward the synthesis of a series of upper-rim-substituted peptoid derivatives of calix[4]arene through the Ugi-4-component reaction (Ugi-4CR) of diisocyano and diamino calix[4]arenes.7 The Ugi-4CR8a occupies a leading position among isocyanide-based multicomponent reactions (IMCR),8b since it represents a valuable method to access a peptide-like moiety, such as α-acylaminocarboxamide, in a straightforward manner by coupling isocyanides with carbonyl compounds, primary amines, and carboxylic acids. The conjugation of multivalent groups at the lower rim of calixarenes involves many steps. Since the lower-rim-functionalized calix[4]arene can provide preorganized binding cores suitable for various ions and molecular species, we were interested in implementing a multicomponent strategy at the lower rim of calix[4]arenes, as it enables the rapid functionalization with promising complexity and diversity by a simple one-pot reaction with great efficiency. Here, we demonstrate a versatile synthesis of the lowerrim-substituted calix[4]arene peptoids based on e Ugi-4CR
Article /joc
Narrow-Rim Functionalization of Calix[4]arene through Ugi-4CR: Synthesis of a Series of Calix[4]arene Peptoids
Anupriya Savithri,† Sreeja Thulasi,† and Ramavarma Luxmi Varma*,†,‡
Received: November 21, 2013 Published: February 5, 2014
1683
/10.1021/jo4025732 | J. Org. Chem. 2014, 79, 1683−1689
The Journal of Organic Chemistry of calix[4]arene diametrically substituted with benzaldehyde groups.
S Supporting Information *
ABSTRACT: Adaptation of Ugi-4CR for the narrow-rim modification of calix[4]arene toward the synthesis of a series of tripeptoid and tetrapeptoid calix[4]arenes is described. The metal ion/organic cation binding properties of the newly synthesized peptoid calix[4]arenes were also investigated.
13
Article
RESULTS AND DISCUSSION We commenced our investigation on the feasibility of the Ugi reaction at the narrow rim with a 1,3-disubstituted aldehyde functionalized calix[4]arene in the hope that this method would enrich the chemical repertoire of calix[4]arene, because the method provides easy access to tripeptoids.8c The required starting material 1 was synthesized in good yields using previously reported synthetic procedures.9,10 The dialdehyde 1 was then reacted with benzoic acid (2a), toluidine (3a) and cyclohexyl isocyanide (4a) by simply combining the four components in 2,2,2-trifluoroethanol (TFE). Stirring the mixture at room temperature after 48 h gave the highly functionalized α-acylaminocarboxamide derivative 5aaa in 52% yield. When we replaced TFE with a more benign and common solvent such as methanol at room temperature, the product was obtained in 58% yield. However, the same reaction at 50 °C furnished the product 5aaa in 83% yield (Scheme 1). In order to study the scope of the method, we applied the same procedure to different acids and amines. In all cases, the expected products were obtained in good yields (Table 1). When the reaction was repeated with naphthyl isocyanide as one of the components under optimal conditions, it failed to give the desired product. However, a moderate yield of the corresponding product was obtained when the reaction was conducted in TFE at room temperature, affording the tripeptoid 5aab (Table 1, entry 10) in 52% yield. To increase the scope and utility of this route, we then incorporated some biologically relevant amino acids such as N-BOC-gly, N-BOC-L-ala, and N-BOC-L-trp (Table 1, entries 7−9), which would further introduce one more peptoid bond equivalent at the narrow rim. The synthesis of tetrapeptoid derivatives of calix[4]arene is otherwise very difficult and involves multiple steps. We also incorporated the biologically important pyramidine unit as well (Table 1, entry 6). The reaction was shown to be tolerant to a wide range of substituents on the different components. That several useful functionalities such as halo-group-containing substrates capable of undergoing further manipulation were readily incorporated into the final products was particularly pleasing. The products have been characterized by the usual spectroscopic techniques, and their IR, 1H NMR,
相关文档
最新文档